A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo

PHASE2UnknownINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

August 31, 2014

Conditions
Anemia
Interventions
DIETARY_SUPPLEMENT

Ferrochel® 90 mg

Ferrochel® capsule 90 mg, administered orally once daily in the morning after breakfast, for 30 days

DIETARY_SUPPLEMENT

Sumalate® 90 mg

Sumalate® capsule 90 mg, administered orally once daily in the morning after breakfast, for 30 days

DIETARY_SUPPLEMENT

Ferrous fumarate 90 mg

Ferrous fumarate capsule 90 mg, administered orally once daily in the morning after breakfast, for 30 days

DIETARY_SUPPLEMENT

Ferrous Sulfate 90 mg

Ferrous Sulfate capsule 90 mg, administered orally once daily in the morning after breakfast, for 30 days

DIETARY_SUPPLEMENT

Ferric Glycinate 90 mg

Ferric Glycinate capsule 90 mg, administered orally once daily in the morning after breakfast, for 30 days

DIETARY_SUPPLEMENT

Placebo

Placebo capsule, administered orally once daily in the morning after breakfast, for 30 days

Trial Locations (1)

16424

RECRUITING

Laboratory Faculty of Pharmacy, Universitas Indonesia, Depok

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Sprim Advanced Life Sciences

OTHER

lead

Albion

INDUSTRY

NCT02128971 - A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo | Biotech Hunter | Biotech Hunter